Publicis Health acquires Payer Sciences

The newly acquired health marketing agency uses data and analytics to help clients navigate payer behavior and the reimbursement environment.

Publicis Health has acquired Payer Sciences, the Publicis Groupe network said Tuesday, to strengthen the analytics it offers clients and expand its footprint into the reimbursement market.

Payer Sciences is a data- and analytics-driven health marketing agency focused on helping biopharmaceutical manufacturers navigate the U.S. reimbursement environment. The Morristown, N.J.-based firm was founded in 2009 and has a staff of 40 full-time data analysts, payer experts and B2B communications specialists.

EBN-M&A-MergerPlans.2.28.18.pngThe agency will retain its branding and operate as a standalone unit under Publicis. The acquisition price was not disclosed.

“Payer Sciences’ powerful suite of unique software and services enables clients to target and optimize interactions with the entire ecosystem of reimbursement stakeholders, including health plans, insurers, pharmacy benefit managers and other organizations that design or administer pharmacy and medical benefits,” says Publicis Health CEO Alexandra von Plato.

Von Plato also notes Payer’s “proprietary technology and methodologies” as an advantage of the acquisition, saying it has “practical applications for other Groupe clients and industries.”
With more than 5,000 employees around the world, Publicis Health manages 18 agency brands through 40 offices located in seven countries.

More for you

Loading data for hdm_tax_topic #better-outcomes...